Genovate Biotechnology Co Ltd Sustainability Reports
Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company focused on the research, development, and manufacturing of small molecule new drugs and drug formulations. It provides clinical trial monitoring and operates a PIC/S GMP-compliant manufacturing facility.
Sector: Manufacturing
Country: Taiwan
Exchange: Taipei Exchange
FIGI: BBG001S6B3M0
6 reports from 2022 to 2025
- Genovate Biotechnology Co Ltd 2025 Parent Company Only Financial Statements and Independent Auditors' Report
- Genovate Biotechnology Co Ltd 2024 Parent Company Only Financial Statements and Independent Auditors' Report
- Genovate Biotechnology Co Ltd 2024 Annual Report
- Genovate Biotechnology Co Ltd 2023 Parent Company Only Financial Statements and Independent Auditors' Report
- Genovate Biotechnology Co Ltd 2023 Annual Report
